How Indian pharmaceutical companies sell generic versions of branded drugs in US

The process begins with Abbreviated New Drug Application (ANDA) where Indian Pharma companies submit ANDA to US FDA to to market a generic version of a drug

Related Keywords

United States ,India , ,Drug Administration ,Abbreviated New Drug Application ,Hatch Waxman Act ,Drug Price Competition ,Patent Term Restoration ,Indian Pharma Companies ,